Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arild Nesbakken

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Plos One|September 13, 2011
Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptomeStine A Danielsen, Lina Cekaite, Trude H Ågesen, et al.
International Journal of Cancer|August 26, 2011
Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcomeSolveig Sirnes, Jarle Bruun, Matthias Kolberg, et al.
Scandinavian Journal of Gastroenterology|October 11, 2012
Long-term outcome of palliative treatment with self-expanding metal stents for malignant obstructions of the GI tractLene Larssen, Asle W Medhus, Hartwig Körner, et al.
Molecular Cancer|May 13, 2010
Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility lociMarianne Berg, Trude H Agesen, Espen Thiis-Evensen, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 26, 2024
The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltrationUmair Majid, Christian Holst Bergsland, Anita Sveen, et al.
International Journal of Cancer|December 17, 2011
The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancerAnita Sveen, Anne Cathrine Bakken, Trude H Ågesen, et al.
Clinical and Translational Gastroenterology|January 18, 2013
A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumorsDeeqa Ahmed, Stine A Danielsen, Trude H Aagesen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 28, 2019
Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastasesTuva Høst Brunsell, Vanja Cengija, Anita Sveen, et al.
Surgical Endoscopy|April 14, 2011
Patient-reported outcomes in palliative gastrointestinal stenting: a Norwegian multicenter studyLene Larssen, Asle W Medhus, Marianne J Hjermstad, et al.
International Journal of Cancer|June 21, 2014
The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancersHege Marie Vedeld, Kim Andresen, Ina Andrassy Eilertsen, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Plos One|September 13, 2011
Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptomeStine A Danielsen, Lina Cekaite, Trude H Ågesen, et al.
International Journal of Cancer|August 26, 2011
Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcomeSolveig Sirnes, Jarle Bruun, Matthias Kolberg, et al.
Scandinavian Journal of Gastroenterology|October 11, 2012
Long-term outcome of palliative treatment with self-expanding metal stents for malignant obstructions of the GI tractLene Larssen, Asle W Medhus, Hartwig Körner, et al.
Molecular Cancer|May 13, 2010
Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility lociMarianne Berg, Trude H Agesen, Espen Thiis-Evensen, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 26, 2024
The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltrationUmair Majid, Christian Holst Bergsland, Anita Sveen, et al.
International Journal of Cancer|December 17, 2011
The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancerAnita Sveen, Anne Cathrine Bakken, Trude H Ågesen, et al.
Clinical and Translational Gastroenterology|January 18, 2013
A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumorsDeeqa Ahmed, Stine A Danielsen, Trude H Aagesen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 28, 2019
Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastasesTuva Høst Brunsell, Vanja Cengija, Anita Sveen, et al.
Surgical Endoscopy|April 14, 2011
Patient-reported outcomes in palliative gastrointestinal stenting: a Norwegian multicenter studyLene Larssen, Asle W Medhus, Marianne J Hjermstad, et al.
International Journal of Cancer|June 21, 2014
The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancersHege Marie Vedeld, Kim Andresen, Ina Andrassy Eilertsen, et al.
Pageof 9